Up next
Author
Tags
Share article
The post has been shared by 0 people.
Facebook 0
Twitter 0
Pinterest 0
Mail 0

The recent $12 billion acquisition of Kite Pharma, Inc. by big-pharma giant, Gilead Sciences has biotech investors hungry for the next big buyout target, which could be…

*Click To Read The Full Article*

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
1 comment
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like
marijuana-stocks-cannabis-CBDOIL

DEA Establishes New Rule Which Makes CBD Oil Illegal…This Is Not A Joke!

Recently the US Drug Enforcement Administration (DEA), somehow managed to shuffle bureaucratic…

Department of Justice Won’t Interfere with Native American Tribal Pot Buisness

The Justice Department announced on Thursday that they have plans to tell…